These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9013991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
    Serreze DV, Leiter EH.
    J Immunol; 1991 Aug 15; 147(4):1222-9. PubMed ID: 1869820
    [Abstract] [Full Text] [Related]

  • 3. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST.
    J Immunol; 1996 Jan 01; 156(1):380-8. PubMed ID: 8598488
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL, Li H, Ildstad ST.
    J Immunol; 1997 Mar 01; 158(5):2435-42. PubMed ID: 9036994
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
    Brenden N, Rietz C, Böhme J.
    Cytokine; 1999 Oct 01; 11(10):766-72. PubMed ID: 10525315
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
    Leijon K, Hillörn V, Bergqvist I, Holmberg D.
    J Autoimmun; 1995 Jun 01; 8(3):347-56. PubMed ID: 7575996
    [Abstract] [Full Text] [Related]

  • 11. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J, Clements W, Field J, Nasa Z, Lock P, Yap F, Toh BH, Alderuccio F.
    J Gene Med; 2006 Nov 01; 8(11):1281-90. PubMed ID: 16989008
    [Abstract] [Full Text] [Related]

  • 12. Immunomodulation through inhibition of multiple adhesion molecules generates resistance to autoimmune diabetes in NOD mice.
    Ninova D, Dean PG, Stegall MD.
    J Autoimmun; 2004 Nov 01; 23(3):201-9. PubMed ID: 15501391
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

  • 15. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.
    Chatenoud L, Primo J, Bach JF.
    J Immunol; 1997 Mar 15; 158(6):2947-54. PubMed ID: 9058834
    [Abstract] [Full Text] [Related]

  • 16. Neonatal induction of allogeneic tolerance prevents T cell-mediated autoimmunity in NOD mice.
    Bendelac A, Boitard C, Bach JF, Carnaud C.
    Eur J Immunol; 1989 Apr 15; 19(4):611-6. PubMed ID: 2525099
    [Abstract] [Full Text] [Related]

  • 17. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN, Burt RK.
    Stem Cells; 2008 Feb 15; 26(2):381-6. PubMed ID: 17975228
    [Abstract] [Full Text] [Related]

  • 18. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis.
    Lee CH, Chen YG, Chen J, Reifsnyder PC, Serreze DV, Clare-Salzler M, Rodriguez M, Wasserfall C, Atkinson MA, Leiter EH.
    Diabetes; 2006 Jan 15; 55(1):171-8. PubMed ID: 16380490
    [Abstract] [Full Text] [Related]

  • 19. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A.
    J Immunol; 1999 Jul 15; 163(2):743-50. PubMed ID: 10395666
    [Abstract] [Full Text] [Related]

  • 20. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
    Serreze DV, Chapman HD, Varnum DS, Gerling I, Leiter EH, Shultz LD.
    J Immunol; 1997 Apr 15; 158(8):3978-86. PubMed ID: 9103469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.